RESUMEN
A 33-year-old male presented with unilateral painless vision loss with a history of sub-tenon steroid for the same. The fundus showed an elevated focus of retinochoroiditis with vitritis. On investigating for the cause, polymerase chain reaction test on the anterior chamber tap was found to be positive for Toxoplasma. Such confusing and atypical cases usually produce a clinical dilemma and should be managed in a stepwise manner. Ancillary investigations usually provide a clue to the clinician and should be performed without any hesitation.
Asunto(s)
Toxoplasma , Toxoplasmosis Ocular , Humanos , Masculino , Adulto , Toxoplasmosis Ocular/diagnóstico , Toxoplasmosis Ocular/tratamiento farmacológico , Toxoplasma/aislamiento & purificación , Toxoplasma/genética , Reacción en Cadena de la Polimerasa , Coriorretinitis/diagnóstico , Coriorretinitis/parasitología , Fondo de Ojo , Infecciones Parasitarias del Ojo/diagnóstico , Infecciones Parasitarias del Ojo/parasitología , ADN Protozoario/análisis , Diagnóstico Diferencial , Angiografía con Fluoresceína/métodosRESUMEN
A woman in her late 30s presented with sudden diminution of vision, redness and pain in the right eye (OD) of 10 days' duration. Best corrected visual acuity (BCVA) was 20/160 in OD and 20/20 in the left eye (OS). Anterior segment of OD showed keratic precipitates, flare 3+, cells 2+ and a festooned pupil. Vitreous haze and cells were seen in OD. Frosted branch angiitis (FBA) was seen in all quadrants in OD and old Toxoplasma scar was seen in both eyes. Serum toxoplasma immunoglobulin G (IgG) was positive and IgM negative, and PCR of an aqueous humour sample was negative for Toxoplasma She was diagnosed with toxoplasa retinochoroiditis in OD and treated with intravitreal clindamycin injections, oral anti-Toxoplasma antibiotics and steroids. Three months later, her BCVA in OD was 20/40 with resolving inflammation. She presented 2 months later with a new focus of retinochoroiditis without FBA and an old Toxoplasma scar.
Asunto(s)
Coriorretinitis , Toxoplasma , Toxoplasmosis Ocular , Humanos , Femenino , Coriorretinitis/tratamiento farmacológico , Coriorretinitis/diagnóstico , Coriorretinitis/parasitología , Toxoplasmosis Ocular/diagnóstico , Toxoplasmosis Ocular/tratamiento farmacológico , Toxoplasmosis Ocular/complicaciones , Toxoplasma/aislamiento & purificación , Adulto , Imagen Multimodal , Vasculitis/tratamiento farmacológico , Vasculitis/diagnóstico , Vasculitis/complicaciones , Agudeza Visual , Clindamicina/uso terapéutico , Clindamicina/administración & dosificación , Tomografía de Coherencia Óptica , Antibacterianos/uso terapéuticoRESUMEN
PURPOSE: To study the role of Toxoplasma IgG avidity in evaluating the stage of systemic infection during manifestation as toxoplasma retinochoroiditis and its clinical implications in eastern India. METHODS: Retrospective chart review of Toxoplasma retinochoroiditis cases with Toxoplasma serology for IgG, IgM, and IgG avidity. RESULTS: Included in this study were 17 eyes of 17 patients who had active retinitis located in the macula (14), mid-periphery (2), or periphery (1). They were either primary lesions (12) or reactivations (5). All the cases had Toxoplasma IgG positive; one case had IgM positivity, while all the cases had high IgG avidity values. IgG avidity had a positive correlation with the duration of symptoms. CONCLUSION: We observed high IgG avidity values in active retinochoroiditis in both primary ocular Toxoplasmosis and reactivation subgroups. These results indicate a late ocular manifestation after initial systemic infection with a possible incubation period ranging from 5 weeks to 5 months.
Asunto(s)
Anticuerpos Antiprotozoarios , Coriorretinitis , Inmunoglobulina G , Toxoplasma , Toxoplasmosis Ocular , Humanos , Toxoplasmosis Ocular/inmunología , Toxoplasmosis Ocular/diagnóstico , Toxoplasmosis Ocular/parasitología , Estudios Retrospectivos , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Femenino , Masculino , Toxoplasma/inmunología , Coriorretinitis/parasitología , Coriorretinitis/inmunología , Coriorretinitis/diagnóstico , Adulto , Anticuerpos Antiprotozoarios/sangre , Anticuerpos Antiprotozoarios/inmunología , Adulto Joven , Adolescente , Niño , Infecciones Parasitarias del Ojo/parasitología , Infecciones Parasitarias del Ojo/diagnóstico , Infecciones Parasitarias del Ojo/inmunología , Inmunoglobulina M/sangre , Inmunoglobulina M/inmunología , Persona de Mediana Edad , Afinidad de Anticuerpos , Estudios de SeguimientoRESUMEN
BACKGROUND: Toxoplasmosis is a zoonotic illness caused by Toxoplasma gondii. Ocular infection frequently manifests as acute necrotizing retinal chorioretinitis. In this paper, we describe a case of retinal chorioretinitis caused by Toxoplasma gondii infection, as well as the most recent diagnostic and treatment techniques. METHODS: Serum and vitreous fluid were collected and analyzed, and PCR for Toxoplasma gondii DNA, ELISA for Toxoplasma gondii IgG and Goldmann-Witmer coefficient, fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), and fundus autofluorescence were done (FAF). RESULTS: Toxoplasma gondii DNA (-), serum and vitreous IgG from Toxoplasma gondii (+) cells, and the Goldmann-Witmer coefficient of Toxoplasma gondii were all considerably enhanced, indicating Toxoplasma gondii infection. Antiparasitic infection in combination with an anti-inflammatory glucocorticoid were given, laser treatment of the fundus was provided, and the patient's condition has been stable with no indication of recurrence to date following conclusion of therapy. CONCLUSIONS: Toxoplasma gondii can infect the whole retina, causing variable degrees of visual impairment; thus, rapid diagnosis and tailored therapy are necessary to enhance prognosis and reduce disease recurrence.
Asunto(s)
Coriorretinitis , Toxoplasma , Toxoplasmosis Ocular , Humanos , Toxoplasmosis Ocular/diagnóstico , Toxoplasmosis Ocular/parasitología , Coriorretinitis/diagnóstico , Coriorretinitis/parasitología , Toxoplasma/genética , Reacción en Cadena de la Polimerasa/métodos , Anticuerpos Antiprotozoarios , Inmunoglobulina GRESUMEN
Toxoplasmic retinochoroiditis is a common, potentially blinding parasitic infection. We sought to define the spectrum and frequency of signs of active toxoplasmic retinochoroiditis by spectral domain optical coherence tomography (SD-OCT), and to identify clinical associations. Ninety eyes of 90 individuals presenting consecutively to a tertiary referral uveitis service with active toxoplasmic retinochoroiditis and gradable SD-OCT scans were evaluated prospectively. SD-OCT features were collated, and associations with lesion location, primary versus recurrent episode, serological status, human immunodeficiency virus infection and best-corrected Snellen visual acuity were explored. Active toxoplasmic retinochoroiditis presented with thickened (65%) and hyperreflective (61%) retina, choroidal thickening (55%) and hyporeflectivity (61%), hyperreflective vitreous dots (80%) and deposits (36%), and posterior hyaloid thickening (35%) on SD-OCT. Most signs occurred with similar frequency across clinical groups. Retinal hyporeflectivity (17%) was significantly associated with a visual acuity of 20/200 or worse at resolution. Our observations demonstrate that active toxoplasmic retinochoroiditis has diverse SD-OCT signs and that none are universally present. Retinal hyporeflectivity-suggesting liquefactive necrosis-predicts poor visual outcome.
Asunto(s)
Coriorretinitis/diagnóstico , Segmento Posterior del Ojo/diagnóstico por imagen , Tomografía de Coherencia Óptica , Toxoplasmosis Ocular/diagnóstico , Adolescente , Adulto , Antiinfecciosos/uso terapéutico , Coriorretinitis/inmunología , Coriorretinitis/parasitología , Quimioterapia Combinada/métodos , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Segmento Posterior del Ojo/inmunología , Toxoplasma/inmunología , Toxoplasma/aislamiento & purificación , Toxoplasmosis Ocular/complicaciones , Toxoplasmosis Ocular/tratamiento farmacológico , Toxoplasmosis Ocular/inmunología , Agudeza Visual , Adulto JovenRESUMEN
PURPOSE: To describe the diagnostic and treatment challenges of a case of presumed acquired macula-involving toxoplasmosis retinochoroiditis. METHODS: Case report of a woman with congenital long QT syndrome presenting with retinochoroiditis after undergoing a cardiac procedure. Laboratory analysis, ocular fluid biopsy, and multimodal imaging were obtained. RESULTS: Ophthalmic examination was significant for decreased vision and a macula-involving chorioretinal lesion concerning for endogenous endophthalmitis. Multimodal imaging showed a focal, full-thickness necrotizing process associated with vitritis, retinal edema, and choroidal thickening. Analysis of peripheral blood revealed elevated serum toxoplasma Immunoglobulin G titers. Blood cultures and a transesophageal echocardiogram were negative for endocarditis. Aqueous and vitreous specimens were negative for an infectious polymerase chain reaction panel, including toxoplasmosis and negative bacterial and fungal cultures. A diagnosis of presumed acquired toxoplasmosis retinochoroiditis was made and treated with a combination of oral and intravitreal antiparasitic medications resulting in healing of the retinochoroiditis. CONCLUSION: To the authors' knowledge, this is the first reported case of acquired toxoplasmosis retinochoroiditis in an immunocompetent patient with congenital long QT syndrome masquerading as endogenous endophthalmitis. The association of congenital long QT syndrome and a recent cardiac procedure with a risk for endogenous endophthalmitis complicated the diagnosis, clinical course, and treatment options. Our case emphasizes the importance of a thorough patient history, comprehensive clinical examination, and supportive multimodal imaging that were used to characterize the infectious process and guide empirical treatment. In addition, laboratory analysis, comanagement with other specialists, and evaluating the response to antitoxoplasma therapy were all instrumental in the eventual diagnosis and treatment of ocular toxoplasmosis in this atypical case.
Asunto(s)
Coriorretinitis , Endoftalmitis , Síndrome de QT Prolongado , Mácula Lútea , Toxoplasmosis Ocular , Coriorretinitis/diagnóstico , Coriorretinitis/parasitología , Endoftalmitis/diagnóstico , Femenino , Humanos , Mácula Lútea/patología , Toxoplasmosis Ocular/diagnósticoRESUMEN
BACKGROUNDS: PCR is a proper technique that significantly improves toxoplasmosis diagnosis. However, a more sensitive technique is required. This study compared real-time PCR with nested PCR using B1, SAG-4, and MAG-1 bradyzoite genes to diagnose toxoplasmosis in toxoplasmic retinochoroiditis patients. METHODS: Blood samples were collected from 10 patients with active toxoplasmic chorioretinal lesions and 10 healthy individuals. Blood samples including peripheral blood mononuclear cells (PBMCs), serum and whole blood samples were used for DNA extraction. Serum was also used to detect anti-toxoplasma IgG and IgM antibodies. Nested PCR and real-time PCR were performed using B1, SAG-4, and MAG-1 target genes. RESULTS: Five (50%) out of the 10 patients were tested positive for toxoplasmosis with nested PCR using the PBMC samples. All the five patients tested positive with nested PCR were also tested positive for toxoplasmosis with real-time PCR using the PBMC samples. The real-time PCR results demonstrated that 9(90%) out of the 10 patients were positive based on B1 and the remaining one (10%) was positive only based on MAG-1. In general, of the patients, five (50%) were positive using SAG-4 and three (30%) were positive in term of MAG-1 using PBMCs with real-time PCR. CONCLUSION: It appears that PBMC samples have the best performance as the PCR extraction method and are a good source for toxoplasmosis diagnosis. The use of B22 and B23 target genes due to their high sensitivity and specificity along with bradyzoite genes are recommended for toxoplasmosis diagnosis using PBMC samples with real-time PCR.
Asunto(s)
Coriorretinitis/parasitología , Toxoplasma , Toxoplasmosis , Anticuerpos Antiprotozoarios , ADN Protozoario/genética , Humanos , Leucocitos Mononucleares , Reacción en Cadena en Tiempo Real de la Polimerasa , Toxoplasma/genética , Toxoplasmosis/diagnósticoRESUMEN
Background: Endogenous fungal endophthalmitis is a sight-threatening condition with potentially devastating outcome. Hematogenous spread of the infective seedings is the route of infection. Infected individuals have usually a compromised immune status. The clinical picture of mycotic endogenous endophthalmitis is commonly seen as chorioretinitis. Candida is the most common fungus. Cladosporium causing endogenous endophthalmitis is a rare occurrence, with only a few cases published.Methods: The report includes study and management of a diabetic patient with endogenous cladosporium endophthalmitis mimicking toxoplasma retinochoroiditis.Results: Diagnosis was confirmed as Cladosporium Cladosporioides in vitreous and aqueous aspirate by polymerase chain reaction-based DNA sequencing. Patient was successfully managed with intravitreal and systemic voriconazole.Conclusion: Cladosporium can cause endogenous endophthalmitis and mimic toxoplasma retinochoroiditis. Vitreous biopsy can help in diagnosis in the absence of positive blood culture. Intravitreal voriconazole along with systemic voriconazole shows a good response.
Asunto(s)
Coriorretinitis/diagnóstico , Cladosporium/aislamiento & purificación , Endoftalmitis/diagnóstico , Infecciones Fúngicas del Ojo/diagnóstico , Micosis/diagnóstico , Toxoplasmosis Ocular/diagnóstico , Adulto , Antifúngicos/uso terapéutico , Humor Acuoso/microbiología , Coriorretinitis/parasitología , Cladosporium/genética , ADN de Hongos/genética , Endoftalmitis/tratamiento farmacológico , Endoftalmitis/microbiología , Infecciones Fúngicas del Ojo/tratamiento farmacológico , Infecciones Fúngicas del Ojo/microbiología , Humanos , Masculino , Micosis/tratamiento farmacológico , Micosis/microbiología , Reacción en Cadena de la Polimerasa , Toxoplasmosis Ocular/parasitología , Cuerpo Vítreo/microbiología , Voriconazol/uso terapéuticoRESUMEN
BACKGROUND: Retinochoroiditis is the most frequent manifestation of congenital toxoplasmosis. We aimed to describe the ocular outcome and factors that may influence the visual prognosis of these patients. METHODS: Cohort of patients with confirmed congenital toxoplasmosis seen between 1996 and 2017 in Porto Alegre, southern Brazil. RESULTS: Seventy-seven patients were included, of which 65 (85.5%) were identified by routine screening. Median age at the end of the follow-up was 10 years (minimum 2, maximum 25). Retinochoroiditis was present in 55 patients (71.4%). New retinochoroidal lesions developed after the first year of life in 77.8% of the patients who began treatment after the fourth month of life, compared with 35.2% among those treated before 4 months of life (relative risk = 0.45, 95% confidence intervals: 0.27-0.75, P = 0.02) and 33.3% among those treated before 2 months of life (relative risk = 0.42, 95% confidence intervals: 0.25-0.72, P = 0.01). There was a peak incidence of new retinochoroidal lesions between 4 and 5 years and another peak between 9 and 14 years, the latter only among girls. Thirty-four patients with retinochoroiditis were followed up for 10 years or more, and the school performance was appropriate in 28 (82.4%). CONCLUSIONS: The high incidence of new retinochoroidal lesions during the follow-up period indicates the importance of long-term follow-up of patients with congenital toxoplasmosis. Initiating treatment within the first 4 months of life, especially within the first 2 months, was a protective factor against the later development of retinochoroiditis. Despite the usual favorable prognosis, the high morbidity of congenital toxoplasmosis in Brazil was confirmed.
Asunto(s)
Coriorretinitis , Toxoplasmosis Congénita , Adolescente , Adulto , Anticuerpos Antiprotozoarios/sangre , Brasil , Niño , Preescolar , Coriorretinitis/diagnóstico , Coriorretinitis/epidemiología , Coriorretinitis/parasitología , Coriorretinitis/fisiopatología , Femenino , Humanos , Incidencia , Masculino , Pronóstico , Recurrencia , Estudios Retrospectivos , Factores de Riesgo , Toxoplasmosis Congénita/complicaciones , Toxoplasmosis Congénita/diagnóstico , Toxoplasmosis Congénita/epidemiología , Toxoplasmosis Congénita/fisiopatología , Agudeza Visual , Adulto JovenRESUMEN
Ocular toxoplasmosis is a retinitis -almost always accompanied by vitritis and choroiditis- caused by intraocular infection with Toxoplasma gondii. Depending on retinal location, this condition may cause substantial vision impairment. T. gondii is an obligate intracellular protozoan parasite, with both sexual and asexual life cycles, and infection is typically contracted orally by consuming encysted bradyzoites in undercooked meat, or oocysts on unwashed garden produce or in contaminated water. Presently available anti-parasitic drugs cannot eliminate T. gondii from the body. In vitro studies using T. gondii tachyzoites, and human retinal cells and tissue have provided important insights into the pathogenesis of ocular toxoplasmosis. T. gondii may cross the vascular endothelium to access human retina by at least three routes: in leukocyte taxis; as a transmigrating tachyzoite; and after infecting endothelial cells. The parasite is capable of navigating the human neuroretina, gaining access to a range of cell populations. Retinal Müller glial cells are preferred initial host cells. T. gondii infection of the retinal pigment epithelial cells alters the secretion of growth factors and induces proliferation of adjacent uninfected epithelial cells. This increases susceptibility of the cells to parasite infection, and may be the basis of the characteristic hyperpigmented toxoplasmic retinal lesion. Infected epithelial cells also generate a vigorous immunologic response, and influence the activity of leukocytes that infiltrate the retina. A range of T. gondii genotypes are associated with human ocular toxoplasmosis, and individual immunogenetics -including polymorphisms in genes encoding innate immune receptors, human leukocyte antigens and cytokines- impacts the clinical manifestations. Research into basic pathogenic mechanisms of ocular toxoplasmosis highlights the importance of prevention and suggests new biological drug targets for established disease.
Asunto(s)
Toxoplasmosis Ocular/etiología , Animales , Coriorretinitis/diagnóstico , Coriorretinitis/parasitología , Coriorretinitis/terapia , Infecciones Parasitarias del Ojo/diagnóstico , Infecciones Parasitarias del Ojo/parasitología , Infecciones Parasitarias del Ojo/terapia , Humanos , Toxoplasma/patogenicidad , Toxoplasmosis Ocular/diagnóstico , Toxoplasmosis Ocular/terapiaRESUMEN
A 9-year-old otherwise healthy boy was examined due to a 4-day history of visual decline in his right eye. Ophthalmological examination revealed an area of active retinochoroiditis in the right macula. Indocyanine green angiography (ICGA) demonstrated multiple hypocyanescent dots surrounding the active lesion extending 360 degrees towards the equator. Optical coherence tomography angiography (OCTA) exhibited dark dots on the choriocapillaris slab over areas corresponding to the hypocyanescent dots detected with ICGA. Full systemic examination and laboratory investigations were carried out. Toxoplasma gondii serology was positive. The diagnosis of toxoplasmic chorioretinitis with white dot-like choroidal involvement was made. Trimethoprim/sulfamethoxazole, azithromycin, and oral prednisolone were administered orally. On repeated ICGA 2 weeks later, the scattered hypocyanescent dots were significantly fewer in number. A month later, right visual acuity was improved, the macular chorioretinitis focus had become inactive, an epiretinal membrane had formed, and the dark dots on the choriocapillaris slab of OCTA were markedly diminished. ICGA may be helpful to observe possible, subtle choroidal involvement in patients with toxoplasmic chorioretinitis.
Asunto(s)
Coriorretinitis/diagnóstico , Coroides/patología , Infecciones Parasitarias del Ojo/diagnóstico , Angiografía con Fluoresceína/métodos , Verde de Indocianina/farmacología , Tomografía de Coherencia Óptica/métodos , Toxoplasmosis Ocular/diagnóstico , Enfermedad Aguda , Animales , Niño , Coriorretinitis/parasitología , Coroides/parasitología , Colorantes/farmacología , Infecciones Parasitarias del Ojo/parasitología , Fondo de Ojo , Humanos , Masculino , Toxoplasma/aislamiento & purificación , Toxoplasmosis Ocular/parasitología , Agudeza VisualRESUMEN
Importance: The 2-year ophthalmic sequelae of Ebola virus disease (EVD) in survivors of the 2013 to 2016 epidemic is unknown and may have public health implications for future outbreaks. Objective: To assess the potential for uveitis recurrence, the behavior of dark without pressure, and visual outcomes in a cohort of Sierra Leonean survivors of EVD 2 years following the 2013 to 2016 Ebola epidemic. Design, Setting, and Participants: Prospective, 1-year observational cohort study performed between 2016 and 2017 at 34 Military Hospital, Freetown, Sierra Leone. Participants included survivors of EVD who reported ocular symptoms since Ebola treatment unit discharge and were participants of a previous case-control study. Participants were invited for ophthalmic reexamination and finger-prick blood sampling for immunoglobulin G (IgG) to Toxoplasma gondii and HIV. Exposures: Ebola virus disease. Main Outcomes and Measures: Primary outcome measure: comparative ultra-widefield retinal imaging. Secondary outcome measures: visual acuity and detection of IgG to T gondii and HIV. Results: Of 57 survivors of EVD who underwent repeated ophthalmic evaluation, 37 were women (64.9%). Mean (SD) age was 31.9 (11.1) years. Median interval between first and last examination was 370 days (interquartile range [IQR], 365-397.5 days), and median time from discharge to last examination was 779 days (IQR, 732-821 days). Fifteen eyes of 10 survivors (17.5%) had retinal lesions secondary to EVD. No new EVD-associated retinal lesions were observed. Two survivors (3.5%) developed new posterior uveitis resembling toxoplasmosis chorioretinitis and 41 (73%) were seropositive for T gondii IgG. Areas of dark without pressure were observed either confined to the perimeter of Ebola retinal lesions (n = 7) and non-Ebola lesions (n = 2), involving extensive retinal areas adjacent to Ebola retinal lesions (n = 4) and non-Ebola lesions (n = 2) or in isolation (n = 6). Both expansion and regression of areas of dark without pressure were observed over the study period. Best eye-presenting visual acuity had mild or no visual impairment in 55 survivors (96.4%) 2 years following discharge. Conclusions and Relevance: Vision was maintained in survivors of EVD 2 years following discharge. Evolving regions of dark without pressure may be associated with EVD retinal lesions and might suggest the presence of an ongoing intraretinal stimulus, which may be associated with infective etiology. Treatment strategies should account for the possibility of toxoplasmosis chorioretinitis recurrence within survivors of EVD.
Asunto(s)
Infecciones Virales del Ojo/diagnóstico , Fiebre Hemorrágica Ebola/diagnóstico , Enfermedades de la Retina/diagnóstico , Sobrevivientes , Uveítis Posterior/diagnóstico , Adulto , Anticuerpos Antiprotozoarios/sangre , Estudios de Casos y Controles , Coriorretinitis/diagnóstico , Coriorretinitis/epidemiología , Coriorretinitis/parasitología , Ebolavirus , Infecciones Parasitarias del Ojo/diagnóstico , Infecciones Parasitarias del Ojo/epidemiología , Infecciones Parasitarias del Ojo/parasitología , Infecciones Virales del Ojo/epidemiología , Femenino , Estudios de Seguimiento , Fiebre Hemorrágica Ebola/epidemiología , Humanos , Inmunoglobulina G/sangre , Masculino , Estudios Prospectivos , Enfermedades de la Retina/epidemiología , Sierra Leona/epidemiología , Tomografía de Coherencia Óptica , Toxoplasma/inmunología , Uveítis Posterior/epidemiología , Agudeza Visual/fisiologíaAsunto(s)
Coriorretinitis/complicaciones , Coriorretinitis/parasitología , Desprendimiento de Retina/complicaciones , Toxoplasmosis Ocular/complicaciones , Coriorretinitis/diagnóstico , Coriorretinitis/tratamiento farmacológico , Esquema de Medicación , Femenino , Angiografía con Fluoresceína , Fondo de Ojo , Humanos , Leucovorina/administración & dosificación , Pirimetamina/administración & dosificación , Desprendimiento de Retina/diagnóstico , Desprendimiento de Retina/tratamiento farmacológico , Sulfadiazina/administración & dosificación , Tomografía de Coherencia Óptica , Toxoplasmosis Ocular/diagnóstico , Toxoplasmosis Ocular/tratamiento farmacológico , Adulto JovenRESUMEN
PURPOSE: To compare the effects of 1 year of treatment with trimethoprim-sulfamethoxazole (TMP-SMZ) vs placebo in reducing the risk of recurrence of toxoplasmic retinochoroiditis during a 6-year follow-up period. DESIGN: Randomized, double-masked clinical trial. METHODS: This cohort included 141 subjects recruited in Campinas, Brazil. The inclusion criterion was unilateral active recurrent toxoplasmic retinochoroiditis. All subjects were treated with 1 dose of TMP-SMZ (160 mg/800 mg) twice daily for 45 days, and all lesions healed after this treatment. After this initial treatment, subjects were randomly assigned to group 1 (1 TMP-SMZ dose every other day for 311 days) or group 2 (1 identical placebo tablet containing starch with no active ingredients every other day for 311 days). Between the second and sixth years of follow-up appointments, none of the subjects received treatment unless a new recurrence episode had occurred. The primary outcomes were recurrent toxoplasmic retinochoroiditis within the first year of follow-up and recurrent toxoplasmic retinochoroiditis in the 6 years of follow-up. RESULTS: The cumulative probability of recurrence 1, 2, 3, 4, 5, and 6 years after the initial infection was, respectively, 13.0% (9/69), 17.4% (12/69), 20.3% (14/69), 23.2% (16/69), 26.1% (18/69), and 27.5% (19/69) in the placebo group and 0%, 0%, 0%, 0%, 0%, and 1.4% (1/72) in the TMP-SMZ group (P < .001; log-rank test). There were 3 cases (3/69; 4.3%) of multiple recurrences in the same individual in the placebo group. No treatment-limiting toxicity or side effects were observed in either group. New recurrences were more frequent among female subjects. CONCLUSIONS: TMP-SMZ may be used safely for prophylaxis of recurrent toxoplasmic retinochoroiditis and may provide long-term benefits.
Asunto(s)
Antibacterianos/uso terapéutico , Coriorretinitis/prevención & control , Infecciones Parasitarias del Ojo/prevención & control , Toxoplasmosis Ocular/prevención & control , Combinación Trimetoprim y Sulfametoxazol/uso terapéutico , Adulto , Coriorretinitis/diagnóstico , Coriorretinitis/parasitología , Método Doble Ciego , Infecciones Parasitarias del Ojo/diagnóstico , Infecciones Parasitarias del Ojo/parasitología , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Recurrencia , Prevención Secundaria , Toxoplasmosis Ocular/diagnóstico , Toxoplasmosis Ocular/parasitología , Agudeza Visual/fisiología , Adulto JovenRESUMEN
BACKGROUND: Ocular toxoplasmosis is a common cause of ocular inflammation worldwide. The aim of this study is to characterize the clinical outcomes and lesion evolution of patients with ocular toxoplasmosis and to compare the primary and reactivation subgroups. METHODS: A retrospective population-based cohort study at one uveitis-specialized tertiary referral center. Patients presenting with active ocular toxoplasmosis between the years 2007-2016 were included. Primary ocular toxoplasmosis and reactivations were compared. RESULTS: Included were 22 patients, 64% female with a mean age of 29 ± 18 years, 59% (n = 13) were primary, 9% (n = 2) congenital and 32% (n = 7) reactivations. Visual acuity improved from 0.38 ± 0.44 to 0.20 ± 0.27 LogMAR (P = 0.026) after a mean of 37 ± 33 months. Initial lesion size was 2.38 ± 1.1 optic disc areas, reducing to 1.56 ± 1.24 following 2 months (34% reduction, P = 0.028) and to 1.17 ± 0.87 disc areas following one year (51% reduction, P = 0.012). Patients with macula-threatening lesions had worse visual acuity (0.50 ± 0.46 vs. 0.05 ± 0.07 LogMAR, P = 0.047). Primary and reactivation subgroups had similar presentations, visual outcomes and recurrence rates (all P > 0.05). CONCLUSIONS: In this population, primary ocular toxoplasmosis was the most common presentation. Lesion size reduced during the initial months with limited change thereafter and a third of cases recurred. Macula-threatening lesions were associated with worse visual acuity, and no significant differences were seen between the primary and reactivation subgroups.
Asunto(s)
Coriorretinitis/terapia , Coroides/diagnóstico por imagen , Manejo de la Enfermedad , Infecciones Parasitarias del Ojo/terapia , Retina/diagnóstico por imagen , Toxoplasma/aislamiento & purificación , Toxoplasmosis Ocular/terapia , Adolescente , Adulto , Anciano , Niño , Preescolar , Coriorretinitis/parasitología , Coroides/parasitología , Infecciones Parasitarias del Ojo/parasitología , Femenino , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Retina/parasitología , Estudios Retrospectivos , Factores de Tiempo , Toxoplasmosis Ocular/parasitología , Agudeza Visual , Adulto JovenRESUMEN
PURPOSE: To report the novel application of nontreponemal and treponemal antibody to confirm diagnosis of ocular syphilis from vitreous samples. METHODS: Two distinct case reports emphasizing the importance of confirmatory vitreous treponemal antibody. Multimodal imaging of patients was also applied. RESULTS: We report two distinct cases with positive serum treponemal antibody but opposing vitreous treponemal antibody results. One case with a positive vitreous test responded well to antisyphilitic treatment. By contrast, a case with a negative vitreous result was changed to serpiginous choroiditis, eventually cured by immunomodulatory treatment. CONCLUSION: Intraocular fluid analysis of nontreponemal and treponemal antibody may play an important role in ruling out suspected ocular syphilis in settings without a polymerase chain reaction facility, especially immunocompromised patients who are at risk of multiple infections. Further studies are needed to establish the sensitivity and specificity of nontreponemal and treponemal antibody test on vitreous samples.
Asunto(s)
Anticuerpos Antibacterianos/inmunología , Coriorretinitis/parasitología , Infecciones Bacterianas del Ojo/parasitología , Sífilis/parasitología , Treponema/inmunología , Adulto , Coriorretinitis/diagnóstico , Coroides/patología , Diagnóstico Diferencial , Infecciones Bacterianas del Ojo/diagnóstico , Angiografía con Fluoresceína , Fondo de Ojo , Humanos , Masculino , Persona de Mediana Edad , Retina/patología , Sífilis/diagnóstico , Tomografía de Coherencia ÓpticaRESUMEN
PURPOSE: To investigate clinical and biological factors influencing recurrences of severe toxoplasmic retinochoroiditis (TRC) confirmed by aqueous humor analysis. DESIGN: Retrospective case series. METHODS: Retrospective analysis of 87 subjects with severe TRC, proven by positive Goldmann-Witmer coefficient (GWC), Toxoplasma gondii (T. gondii) immunoblot, or T. gondii-specific polymerase chain reaction (PCR) in aqueous humor. Cases with immunosuppression or retinal scars without previous recorded episode were excluded. Time-dependent, clinical, treatment-related, and biological factors were explored by univariate and multivariate shared frailty survival analyses. RESULTS: Among 44 included subjects (age, 40.4 ± 17.6 years; follow-up, 8.3 ± 2.7 years), 22 presented recurrences. There was 0.11 recurrence/patient/year and mean disease-free interval was 5.0 ± 2.9 years. The risk of recurrence was higher immediately after an episode (P < .0001). Among recurrent cases, the risk of multiple recurrences was higher when the first recurrence occurred after longer disease-free intervals (P = .046). In univariate analysis, the recurrence risk declined with higher number of intense bands on aqueous T. gondii immunoblot (P = .006), and increased when venous vasculitis was present initially (P = .019). Multivariate analysis confirmed that eyes with more intense bands on immunoblot had fewer recurrences (P = .041). There was a near-significant risk elevation after pyrimethamine/azithromycin treatment (P = .078 and P = .054, univariate and multivariate). Intravenous corticosteroid administration, oral corticosteroid administration, aqueous GWC, and T. gondii PCR did not influence recurrences (P = .12, P = .10, P = .39, and P = .96, respectively). CONCLUSIONS: Recurrences of severe TRC are not random and may be influenced by clinical and biological factors possibly related to blood-retinal barrier alterations. These results may contribute to identifying biomarkers for TRC reactivation.
Asunto(s)
Humor Acuoso/parasitología , Coriorretinitis/diagnóstico , Infecciones Parasitarias del Ojo/diagnóstico , Toxoplasmosis Ocular/diagnóstico , Administración Oral , Adolescente , Adulto , Anciano , Anticuerpos Antiprotozoarios/inmunología , Factores Biológicos , Coriorretinitis/genética , Coriorretinitis/inmunología , Coriorretinitis/parasitología , ADN Protozoario/genética , Infecciones Parasitarias del Ojo/genética , Infecciones Parasitarias del Ojo/inmunología , Infecciones Parasitarias del Ojo/parasitología , Femenino , Estudios de Seguimiento , Glucocorticoides/administración & dosificación , Humanos , Immunoblotting , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Recurrencia , Estudios Retrospectivos , Toxoplasma/genética , Toxoplasma/inmunología , Toxoplasmosis Ocular/genética , Toxoplasmosis Ocular/inmunología , Toxoplasmosis Ocular/parasitologíaRESUMEN
Purpose: The purpose of this article is to analyze possible associations between systemic and ocular cytokine levels and specific clinical ophthalmologic signs from patients with a reactivation of toxoplasmic retinochoroiditis (RTR). Methods: A total of 18 patients with an active RTR episode, 8 patients with inactive scars, and 14 control patients were included in the study. Serum samples and aqueous humor (AH) samples were analyzed for IFN (interferon)-γ, interleukin (IL)-10, and IL-6 levels by ELISA. Inflammation grade, location, and size of the retinochoroidal active lesion, sampling time, and time to resolution were recorded. Results: A significantly negative correlation between AH and serum levels of IFN-γ was detected (p < 0.05). Patients with an AH IFN-γ/IL-10 ratio lower than 1 were associated with the longest time to resolution and/or severe complications. Conclusion: Serum IFN-γ levels may be used as a prognostic marker for both time to resolution and the development of possible severe complications during a given RTR episode.
Asunto(s)
Biomarcadores/sangre , Coriorretinitis/parasitología , Interferón gamma/sangre , Interleucina-10/sangre , Interleucina-6/sangre , Toxoplasma/fisiología , Toxoplasmosis Ocular/parasitología , Adulto , Antiprotozoarios/uso terapéutico , Humor Acuoso/metabolismo , Coriorretinitis/tratamiento farmacológico , Coriorretinitis/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Factores Inmunológicos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Toxoplasmosis Ocular/tratamiento farmacológico , Toxoplasmosis Ocular/inmunología , Adulto JovenRESUMEN
PURPOSE: To describe swept-source optical coherence tomography and optical coherence tomography angiography retinal changes in a case of acute toxoplasmic chorioretinitis both at the time of diagnosis and after healing. CASE PRESENTATION: A 57-year-old white woman suffering from acquired toxoplasmic chorioretinitis underwent swept-source optical coherence tomography and optical coherence tomography angiography both at the time of diagnosis and after healing. In the acute phase of the disease, swept-source optical coherence tomography clearly showed retinal and choroidal involvement in the superficial retina and in the choroidal swelling. Optical coherence tomography angiography showed a complete loss of deep and superficial capillary networks and of choroidal vessels in the area of the inflammation. After healing, swept-source optical coherence tomography showed a retinal thinning of the area involved, with a subversion of retinal layers and no visible change at the choroid level. On the other hand, optical coherence tomography angiography showed the persistence of a vascular occlusion at the retina and choroid level. CONCLUSION: This is the first case in the optical coherence tomography angiography literature that shows the imaging of toxoplasmic chorioretinal lesions. This case confirms the involvement of the retina and choroid in toxoplasmic uveitis and the disruptive potential of such inflammation. The optical coherence tomography angiography performed after healing showed a persistent ablation of the retina, choriocapillaris, and choroidal vessels. The non-invasive optical coherence tomography angiography imaging technique may have diagnostic and prognostic value in regard to toxoplasmic uveitis.